Alucent Biomedical Revenue and Competitors
Estimated Revenue & Valuation
- Alucent Biomedical's estimated annual revenue is currently $3.6M per year.
- Alucent Biomedical's estimated revenue per employee is $125,500
- Alucent Biomedical's total funding is $35.4M.
Employee Data
- Alucent Biomedical has 29 Employees.
- Alucent Biomedical grew their employee count by 4% last year.
Alucent Biomedical's People
| Name | Title | Email/Phone |
|---|---|---|
1 | President & CEO | Reveal Email/Phone |
2 | Chief Financial Officer | Reveal Email/Phone |
3 | VP - Finance & Administration | Reveal Email/Phone |
4 | VP, Clinical Affairs | Reveal Email/Phone |
5 | VP Research & Development | Reveal Email/Phone |
6 | Plant Manager | Reveal Email/Phone |
7 | Project Manager, Clinical Affairs | Reveal Email/Phone |
Alucent Biomedical Competitors & AlternativesAdd Company
| Competitor Name | Revenue | Number of Employees | Employee Growth | Total Funding | Valuation |
|---|---|---|---|---|---|
#1 | $94.6M | 377 | 28% | N/A | N/A |
#2 | $16.8M | 67 | -17% | N/A | N/A |
#3 | $485.4M | 1934 | 7% | N/A | N/A |
#4 | $43.7M | 174 | 15% | N/A | N/A |
#5 | $75M | 192 | 43% | $12.8M | N/A |
#6 | $6M | 24 | -8% | N/A | N/A |
#7 | $7.3M | 29 | -22% | N/A | N/A |
#8 | $38.4M | 153 | 3% | N/A | N/A |
#9 | $174.4M | 695 | 9% | N/A | N/A |
#10 | $6.8M | 27 | -34% | N/A | N/A |
What Is Alucent Biomedical?
Alucent Medical, Inc. is a privately-held biotechnology company, based in Salt Lake City, UT, developing a novel drug-device combination therapy, Natural Vascular Scaffolding (NVS) for patients with peripheral vascular disease.
keywords:N/A
$35.4M
Total Funding
29
Number of Employees
$3.6M
Revenue (est)
4%
Employee Growth %
N/A
Valuation
N/A
Accelerator
Alucent Biomedical News
2022-04-13 - Alucent Biomedical Announces First Patient Enrolled in First In ...
Alucent Biomedical is a privately held company dedicated to developing and commercializing its breakthrough Natural Vascular Scaffolding (...
2022-04-13 - Alucent Biomedical anounces first patient enrolled in first-in ...
Alucent Biomedical anounces first patient enrolled in first-in-human natural vascular scaffolding clinical trial. 12th April 2022. 3. natural...
Other Companies in Salt Lake City
| Company Name | Revenue | Number of Employees | Employee Growth | Total Funding |
|---|---|---|---|---|
#1 | $5.9M | 29 | -17% | N/A |
#2 | $7.3M | 29 | -22% | N/A |
#3 | $5.1M | 29 | -12% | N/A |
#4 | $4.1M | 29 | 0% | N/A |
#5 | $7.5M | 29 | 0% | N/A |